Corrigendum to 'Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)'
- Resource Type
- article
- Source
- EBioMedicine, Vol 89, Iss , Pp 104486- (2023)
- Subject
Medicine Medicine (General) R5-920 - Language
- English
- ISSN
- 2352-3964